Market closed

DaVita/$DVA

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About DaVita

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Ticker

$DVA
Sector
Health Care

Trading on

NYSE

Industry

Health Care Providers & Services
Headquarters
Denver, United States

Employees

70,000
Website
www.davita.com

DaVita Metrics

BasicAdvanced
$13B
16.99
$9.24
0.89
-

$13B

0.89

$165.57

$103.40

636K

1.371

1.265

517.98

549.552

3.69%

6.84%

44.88%

16.99

1.081

33.56

-1.84

9.671

6.34%

41.03%

3.03%

2.59%

What the Analysts think about DaVita

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for DaVita stock.

DaVita Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

DaVita Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

DaVita News

AllArticlesVideos
DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

Seeking Alpha·2 months ago
Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due

Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due

Investors Business Daily·3 months ago
DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript

DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript

Seeking Alpha·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $DVA

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for DaVita stock?

DaVita (DVA) has a market cap of $13B as of January 15, 2025.

What is the P/E ratio for DaVita stock?

The price to earnings (P/E) ratio for DaVita (DVA) stock is 16.99 as of January 15, 2025.

Does DaVita stock pay dividends?

No, DaVita (DVA) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next DaVita dividend payment date?

DaVita (DVA) stock does not pay dividends to its shareholders.

What is the beta indicator for DaVita?

DaVita (DVA) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.